LICA PHARMACEUTICALS ApS: Financial statements 2013
CVR: 25332520
LICA PHARMACEUTICALS ApS (CVR 25332520) has filed annual accounts for 2013. In 2013, the company reported a gross profit of DKK 341,415 and a net result of DKK 782,891 compared with DKK 953,184 the year before. That is an increase of 15.5% compared with the year before. Equity amounted to DKK 10,041,017. The solvency ratio was 99.8%.
- Gross Profit
- 341,415 kr.
- Profit/Loss
- 782,891 kr.
- Equity
- 10,041,017 kr.
- Total Assets
- 10,057,211 kr.
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2013 | - | 341 t. | 783 t. | 10 mio. | - |
| 2012 | 468 t. | 296 t. | 953 t. | 9.3 mio. | - |
Find more companies like LICA PHARMACEUTICALS ApS
Build lead lists with filters on industry, geography, size and financials — and export straight to Excel.
Try the lead list generatorEvents in 2013
LICA PHARMACEUTICALS ApS has published its annual report for 2012. Revenue came to DKK 468,291, and the net result was DKK 953,184.
About LICA PHARMACEUTICALS ApS
LICA PHARMACEUTICALS ApS is a Danish company of the type Anpartsselskab based in Hellerup, founded in 2000. The company is registered under the industry Forskning og eksperimentel udvikling inden for naturvidenskab og teknik. The company was previously named LICA PHARMACEUTICALS A/S. The management consists of Arsalan Kharazmi. The company is owned by Arsalan Kharazmi. The company has 1 employee. In 2025, the company reported a gross profit of DKK 359,449 and a net result of DKK 450,710 compared with DKK 1,406,816 the year before. Equity amounted to DKK 24,221,286.
